Zenas BioPharma

About Zenas BioPharma

Zenas BioPharma is dedicated to developing therapies for autoimmune diseases, aiming to address unmet patient needs and transform lives. Their mission is to enable patients with autoimmune diseases to reimagine their lives through purposeful and urgent action.

Products & Services

Obexelimab:An investigational bifunctional monoclonal antibody designed to bind to CD19 and FcγRIIb, suppressing B cell activity, a key factor in many autoimmune diseases. It is advancing through clinical trials to address unmet medical needs.

Pipeline:A collection of programs in development targeting multiple autoimmune diseases.

Specialties

Autoimmune disease therapies Monoclonal antibody development Clinical trials for unmet medical needs

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Royalty Financing T: - FT: Royalty Financing	A: 300000000 MR: - FA: up to $300 million FAN: 300000000	D: 2025-09-02 FD: 2025-09-02	1 investors
2	RT: Funding Agreement T: - FT: Funding Agreement	A: 300000000 MR: - FA: 300 million FAN: 300000000	D: 2025-09-02 FD: 2025-09-02	-
3	RT: Initial Public Offering (IPO) T: - FT: Initial Public Offering (IPO)	A: 258700000 MR: - FA: approximately $258.7 million FAN: 258700000	D: 2024-09-19 FD: 2024-09-19	4 investors
4	RT: Initial Public Offering T: - FT: Initial Public Offering	A: 225000000 MR: - FA: approximately $225.0 million FAN: 225000000	D: 2024-09-12 FD: 2024-09-12	4 investors
5	RT: Series C T: - FT: Series C	A: 200000000 MR: - FA: $200 million FAN: 200000000	D: 2024-05-07 FD: 2024-05-07	15 investors

Royalty Financing Latest

2025-09-02

$300.0M

1 investor (Pro only)

Funding Agreement 2025-09-02

$300.0M

Initial Public Offering (IPO) 2024-09-19

$258.7M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Lonnie Moulder

Chief Executive Officer and Chairman of the Board of Directors

J

Joe Farmer

President and Chief Operating Officer

L

Lisa von Moltke

Head of Research and Development and Chief Medical Officer

J

Jennifer Fox

Chief Business Officer and Chief Financial Officer

H

Haley Laken

Chief Scientific Officer

O

Orlando Oliveira

Chief Commercial Officer

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

Zenas BioPharma Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised